Shimoga Chemicals FDA Record
- Latest inspection OAI · Jan 23, 2026
- Last warning letter 2026
Shimoga Chemicals has 1 FDA recall, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Shimoga Chemicals, the most recent on Jul 13, 2026. FDA has published 1 Form 483 for Shimoga Chemicals.
- Latest recall
- D-0691-2026 · Class II · May 19, 2026
- Latest inspection
- Jan 23, 2026 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Shimoga Chemicals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Shimoga Chemicals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Shimoga Chemicals FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jul 13, 2026 · Letter on fda.gov | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated | Center for Drug Evaluation and Research (CDER) |
Shimoga Chemicals Form 483s
| Date | Document | FEI |
|---|---|---|
| Jan 23, 2026 · Document on fda.gov | 483 | 3033881432 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0691-2026 | Class II | Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC… | May 19, 2026 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 23, 2026 | Sangli, India | Drugs | Official Action Indicated (OAI) | 3033881432 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Shimoga Chemicals: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3033881432 | Sangli, India | 1 | Jan 23, 2026 |
Shimoga Chemicals and the FDA: common questions
Has Shimoga Chemicals received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Shimoga Chemicals. The most recent is dated Jul 13, 2026, with the subject "CGMP/Active Pharmaceutical Ingredient (API)/Adulterated".
Has Shimoga Chemicals received an FDA Form 483?
FDA has published 1 Form 483 for Shimoga Chemicals in its reading room, the most recent dated Jan 23, 2026. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Shimoga Chemicals?
The most recent FDA inspection on file ended Jan 23, 2026 at Sangli, India and was classified OAI. FDA has 1 inspection of Shimoga Chemicals on file, 1 of them classified OAI (official action indicated).
Has Shimoga Chemicals had an FDA recall?
Yes. Shimoga Chemicals has 1 FDA recall on record. The most recent started May 19, 2026.
Need more than this page shows? Ask about Shimoga Chemicals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.